News
AstraZeneca (LSE:AZN) recently launched "FluMist Home," an at-home flu vaccine delivery service, marking an important ...
FluMist has been approved since 2003, but, until last year, only for administration by a healthcare practitioner. The new nod ...
AstraZeneca PLC closed 13.46% below its 52-week high of £133.88, which the company reached on September 3rd.
Today’s Forbes CFO newsletter focuses on Aradhana Sarin’s journey from treating patients to becoming what she calls a ...
Detailed price information for Astrazeneca Plc Ord (AZNCF) from The Globe and Mail including charting and trades.
He said about Britain that the firm needed “to see that there is access and a reason to invest.” This is partly a negotiating ...
A panel of the European medicines regulator has recommended approving an eco-friendly version of AstraZeneca's inhaler for ...
AstraZeneca, the U.K.-Swedish pharmaceutical giant, on Tuesday announced a plan to invest some $50 billion in the U.S. in a move hailed by the Trump administration — though much of what it is ...
AstraZeneca PLC thrives with $54B revenue and 14 blockbusters in 2024, fueled by oncology and rare disease growth. Click for ...
AstraZeneca plans to spend $50 billion to expand manufacturing and research capabilities in the U.S. by 2030, it said on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback